Vertex, continuing its rebound, cleared to resume testing of diabetes cell therapy

Vertex, continuing its rebound, cleared to resume testing of diabetes cell therapy

Submitted by admin on July 6, 2022 - 10:33am
Source: 
BioPharma Dive
News Tags: 
Vertex Pharmaceuticals
type 1 diabetes
cell therapy
FDA
Headline: 
Vertex, continuing its rebound, cleared to resume testing of diabetes cell therapy
snippet: 

The Food and Drug Administration has cleared Vertex Pharmaceuticals to resume a study evaluating an experimental cell therapy that has shown promise treating Type 1 diabetes.

Do Not Allow Advertisers to Use My Personal information